#IPF is a rare chronic progressive #pulmonarydisease with abnormal scarring of the lung blocking the movement of oxygen into the bloodstream. #NKT #IdiopathicPulmonaryFibrosis
GRI Bio, Inc.
Biotechnology
San Diego, CA 461 followers
Advancing Pipeline of Natural Killer T Cell Modulators for the Treatment of Inflammatory and Fibrotic Diseases.
About us
GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. NKT cells are innate-like T cells that share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type 1 invariant NKT (iNKT) cells play a critical role in propagating the injury, inflammatory response, and fibrosis observed in inflammatory and fibrotic indications. GRI Bio’s lead program, GRI-0621, is an inhibitor of iNKT cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis, a serious disease with significant unmet need. The Company is also developing a pipeline of novel type 2 NKT agonists for the treatment of systemic lupus erythematosus. Additionally, with a library of over 500 proprietary compounds, GRI Bio has the ability to fuel a growing pipeline.
- Website
-
http://www.gribio.com
External link for GRI Bio, Inc.
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- San Diego, CA
- Type
- Public Company
- Founded
- 2009
- Specialties
- NKT cells, inflammation, hepatitis, autoimmunity, alcoholic liver disease, liver disease, fibrosis, 505(b)(2), Natural Killer T, and drug development
Locations
-
Primary
8954 Rio San Diego Drive
Suite 102
San Diego, CA 92108, US
Employees at GRI Bio, Inc.
Updates
-
Have you had a chance to check out our growing development pipeline? Access it here: https://bit.ly/3NufOdo #IdiopathicPulmonaryFibrosis #IPF #SystemicLupusErythematosus #SLE #NKT
-
We are leveraging #NKT regulation to target earlier in the inflammatory cascade to interrupt disease progression. Learn more here: https://bit.ly/3pRUJAu #AutoimmuneDisease #FibroticDisease #PulmonaryDisease
-
Our CEO, Marc Hertz, PhD, recently presented during the Webull Biotech webinar! Access the webcast replay here: https://lnkd.in/ebkExZW5 #NKT #AutoimmuneDisease #InflammatoryDisease #IPF #SLE
Live With Webull Corporate Connect - Biotech Investment Webinar
-
Learn how we are targeting the upstream in the #inflammatory cascade providing the potential for greater efficacy in #idiopathicpulmonaryfibrosis. https://bit.ly/44PhbZT #PulmonaryDisease #FibroticDisease
GRI-0621 | GRIbio
https://gribio.com
-
GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity. https://bit.ly/4bgvryg #Autoimmunity2024 #AutoimmuneDisease #NKT
GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity | GRIbio
-
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar. https://bit.ly/49VswJY #Webull #NKT #AutoimmuneDisease #FibroticDisease #InflammatoryDisease
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar | GRIbio
https://gribio.com
-
#IdiopathicPulmonaryFibrosis is a rare chronic progressive #pulmonary disease with limited treatment options. #NKT #PulmonaryDisease #FibroticDisease
-
We are dedicated to advancing new therapies through innovative approaches for the treatment of #inflammatory, #fibrotic and #autoimmune diseases. Learn more here: https://bit.ly/44oqkIY #NKT
-
GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent. https://bit.ly/3Q6nLX3 #NKT #InflammatoryDisease #AutoimmuneDisease #FibroticDisease
GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent | GRIb...
https://gribio.com